Crossmark

Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious

Published Online: 2022-02-04

Published Print: 2022-10

Authors

Giri, Suprabhat https://orcid.org/0000-0002-9626-5243
Darak, Harish

Kasturi, Sunil
License Information

Text and Data Mining valid from 2022-02-04

Version of Record valid from 2022-02-04
More Information

Article History

Received: 29 November 2021

Accepted: 10 January 2022

First Online: 4 February 2022

Declarations

:

: All authors declare that they have no conflict of interest.

Document is current